Nanoformulation Strategies for Phoenix dactylifera Bioactives: Phytochemical Profile, Mechanistic Insights, and Translational Challenges

Abstract

Botanical bioactives remain a mainstay in pharmaceutical discovery and development; yet, its translational use in medicine is often hampered due to their low hydrophilicity, chemical liability, accelerated metabolism, and limited system bioavailability. Phoenix dactylifera L. (date palm tree) is a dietary as well as medically high-value therapeutic herb known to be high in polyphenols, flavonoids, carotenoids, sterols, dietary fibers, and micronutrients and exhibiting established and documented antioxidant, anti-inflammatory, metabolic, and cytoprotective properties. Regardless of their ideal and spectacular multitargeted biological characterization and activity, their therapeutic and pharmaceutical use particularly concerning their active principles remains limited and hampered due to formulation-based problems. The present review aims to provide a global as well as current synthesis on nanoformulation approaches for herbal phytoconstituents with a special focus on their possible and pertinent use on P. dactylifera bioactives. The objective is to examine and critique several nanocarrier systems containing polymeric nanoparticles, lipid nanocarriers (solid Lipid Nanoparticles/Nano-Structured Lipid Carriers and liposomes), nanoemulsions, nanogels, and metallic nanoparticles synthesized through green methods. These nano-systems are evaluated on their possible roles and uses in improving solubility, confining breakdown, facilitating cellular uptake, controlling and regulating sustained and targeted drug delivery.

Introduction: Phoenix dactylifera or date palm, a herbal plant of Arecaceae family has antioxidant, anti-inflammatory, antimicrobial, and neuroprotective activities. Its applications in medicine are limited because of lower solubility, stability, and bioavailability.

Objective: To analyse the phytochemical profiling, mechanism of nanoformulation of Phoenix dactylifera for enhancement of therapeutic properties.

Methods: The comprehensive survey of the literatures was performed in PubMed, Scopus, and Google Scholar in order to obtain results from the period of 2001 to 2025 by using keywords of "Phoenix dactylifera," "phytochemical profiling," "mechanism of nanoformulation," and "nanoformulation." Peer-reviewed articles written in English language were considered in order to understand the concept of nanoformulations.

Results: The pharmacological potentials of P. dactylifera involve several biologically active components like flavonoids, phenolic acids, carotenoids, sterols, triterpenoids, polyphenols, tocopherols, and essential oils. Nano-formulation approaches like polymeric nanoparticles, liposomes, nanoemulsions, nanogels, and green-synthesized metallic nanoparticles have been effective enough to enhance solubility, permeability, degradation, and controlled release. Nano-formulation approaches could hold potential to overcome the challenges related to bioavailability and in the fields of pharmaceuticals, nutraceuticals, and cosmeceuticals.

Conclusion: Nanotechnology provides promising solutions towards optimizing the medicinal benefits of Phoenix dactylifera. Further studies are to be done for establishing clinical efficacy, standardization of formulations, and larger-scale productions for broader therapeutic use.